Svetlana Kozireva, PhD, was born in Riga, Latvia and studied at the Faculty of Biology of the Latvian State University, where she received her Master of Science degree.She then earned her Ph.D. degree in virology defending her thesis entitled ‘Anti-sense poly- nucleotides as inhibitors of bovine leukemia virus replication'.
training as a Ph.D. student, Svetlana
became proficient in molecular biology techniques such as real-time PCR.She
specialized in virology, concentrating her
efforts on rabbit myxoma and fibroma viruses and then on retroviruses HTLV-BLV group.In 1980, Svetlana began her career at the August Kirchenstein Institute of Microbiology of the Latvian Academy of Sciences as a technician, continued there as laboratory assistant, and then as senior biologist.At present, she is a researcher at the same institution.Svetlana
has been deeply motivated to improve her
scientific knowledge and skills.Proof of this fact is that she was a guest researcher at the All-Russia Institute of Agricultural Biotechnology; in the Virology section of the Department of Medical Sciences at Uppsala University; and in the Department of Tumorbiology and Microbiology of the Karolinska Institute in Stockholm, Sweden.She also spent time at the Ludwig Boltzman Institute for Leukemia Research in Vienna, Austria.Svetlana
participates in two European societies: The European Society for Veterinary Virology and the European Tissue Culture Society
.In addition, she
has published 13 scientific articles, some in Russian, and others in international scientific journals such as the International Journal of Cancer
, Experimental Oncology, and the Journal of Neurovirology.Heidrun Karloc, PhD, Svetlana's mentor in Vienna, commented that she is a hard-working researcher, willing to master new methods and fields, and always open-minded in her interactions with her colleagues in the laboratory.
Svetlana's current scientific interest is in the field of oncovirology, and her
research involves the epidemiology, and molecular biology of the blood-borne viruses, and their association with hematologic malignancies.